|12 Months Ended|
Sep. 30, 2021
|Share-based Payment Arrangement [Abstract]|
The Company grants restricted stock units ("RSUs") and performance stock units ("PSUs") to eligible participants under its 2017 Stock Incentive Plan, which was approved by the Board of Directors and stockholders. The RSUs granted to employees vest ratably over or five years and one year for members of the board of directors, in each case from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three year-performance period. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
In addition to the non-vested shares, as part of individual elections made in the deferred compensation plan, certain directors and employees held approximately 268,000 vested but not issued awards as of September 30, 2021. These vested unissued units are included in outstanding shares for basic and diluted earnings per share, but are not reported as issued and outstanding in the Consolidated Balance Sheets and Consolidated Statements of Changes in Shareholders' Equity.
As of September 30, 2021, the intrinsic value of RSUs and PSUs expected to vest was $59.0 million.
For the years ended September 30, 2021, 2020, and 2019, the Company recognized share-based compensation expenses of $28.6 million, $23.7 million, and $20.8 million, respectively. The income tax benefit recorded on these charges for the same years was $13.5 million, $8.0 million, and $9.9 million, respectively. The expenses related to share-based compensation awards are recorded in selling and administrative expenses. As of September 30, 2021, there was $45.7 million of total estimated unrecognized compensation cost related to non-vested RSUs and PSUs. This cost is expected to be recognized over a weighted average period of 1.3 years.
The weighted-average grant-date fair value of RSUs granted in years ended September 30, 2020 and 2019, was $74.26 and $66.96, respectively. The total fair value of RSUs vested during the years ended September 30, 2021, 2020 and 2019 was $28.9 million, $23.6 million, and $27.4 million, respectively.
Accumulated Other Comprehensive Income
Stock Repurchase Programs
Under a resolution adopted in March 2020, the Board of Directors authorized the purchase, at management's discretion, of up to $200.0 million of our common stock. This supplemented a similar resolution adopted in June 2018. During the years ended September 30, 2021, 2020, and 2019, the Company purchased 0.1 million, 2.8 million, and 0.7 million common shares at a cost of $3.4 million, $167.0 million, and $46.8 million, respectively. As of September 30, 2021, $146.7 million remained available for future stock repurchases.
The entire disclosure for share-based payment arrangement.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef